Valuation: Hologic, Inc.

Market Cap 16.97B 14.85B 13.69B 12.68B 24.08B 1,610B 24.47B 164B 63.81B 795B 63.71B 62.33B 2,747B P/E 2024
24.3x
P/E 2025 27x
Enterprise Value 17.39B 15.22B 14.02B 13B 24.68B 1,650B 25.07B 168B 65.4B 815B 65.29B 63.87B 2,815B EV / Sales 2024
4.74x
EV / Sales 2025 3.75x
Free-Float
73.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
6 months+1.40%
Current year+2.04%
Current year 74.49
Extreme 74.49
76.07
1 year 63.19
Extreme 63.1923
76.07
3 years 51.9
Extreme 51.9
84.67
5 years 51.9
Extreme 51.9
87.88
10 years 26.49
Extreme 26.49
87.88
Manager TitleAgeSince
Chief Executive Officer 63 07/04/2026
Director of Finance/CFO - 16/04/2026
Chief Operating Officer 46 01/01/2024
Director TitleAgeSince
Director/Board Member 63 07/04/2026
Date Insider Type Main position Quantity % Market Cap.
07/04Issuer sale

Director

65,866 0.0295%
07/04Issuer sale

Chief Executive Officer

4,928,217 2.2075%
07/04Issuer sale

Director

56,632 0.0254%
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-.--%+18.08%-1.94% 16.97B
-0.19%+3.04%+23.39%+0.56% 192B
-1.28%+7.45%-20.09%+28.98% 151B
+0.29%+1.95%-2.73%-16.69% 137B
+1.57%+6.14%-56.37%-13.37% 67.33B
-0.38%+4.82%+23.64%+5.05% 54.6B
-2.50%+0.15%-26.50%-30.92% 44.94B
-1.05%-0.03%+8.13%+41.94% 36.81B
+0.41%-1.27%+9.97%+12.09% 37.04B
+0.62%+12.76%-14.30%+1.83% 31.7B
Average +0.07%+4.00%-3.68%+2.75% 77.02B
Weighted average by Cap. +0.28%+4.01%-2.72%+2.86%

Financials

2024 2025
Net sales 4.03B 3.53B 3.25B 3.01B 5.72B 383B 5.81B 38.98B 15.16B 189B 15.13B 14.8B 652B 4.1B 3.59B 3.31B 3.07B 5.82B 389B 5.91B 39.65B 15.42B 192B 15.39B 15.06B 664B
Net income 790M 691M 637M 590M 1.12B 74.93B 1.14B 7.63B 2.97B 36.98B 2.96B 2.9B 128B 566M 495M 456M 423M 803M 53.69B 816M 5.47B 2.13B 26.5B 2.12B 2.08B 91.59B
Net Debt 321M 281M 259M 240M 456M 30.49B 463M 3.11B 1.21B 15.05B 1.21B 1.18B 52.02B 421M 368M 339M 315M 597M 39.95B 607M 4.07B 1.58B 19.71B 1.58B 1.55B 68.14B
Logo Hologic, Inc.
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Employees
7,070
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. HOLX Stock